BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24596386)

  • 1. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
    Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
    Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
    Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
    Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast.
    Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS
    Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.
    Chung MJ; Jung SH; Lee BJ; Kang MJ; Lee DG
    Pathol Int; 2004 Jan; 54(1):10-5. PubMed ID: 14674989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
    Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
    Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of PTEN Gene Expression and Length of Survival of Breast Cancer Patients in the North East of Iran.
    Golmohammadi R; Rakhshani MH; Moslem AR; Pejhan A
    Asian Pac J Cancer Prev; 2016; 17(S3):305-9. PubMed ID: 27165243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
    Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
    Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIK3CA and PTEN Genes Expressions in Breast Cancer.
    Alowiri NH; Hanafy SM; Haleem RA; Abdellatif A
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2841-2846. PubMed ID: 31554385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 16q loss--a genetic key to the understanding of breast carcinogenesis.
    Bürger H; de Boer M; van Diest PJ; Korsching E
    Histol Histopathol; 2013 Mar; 28(3):311-20. PubMed ID: 23348384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
    de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
    Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population.
    Rizvi MM; Alam MS; Mehdi SJ; Ali A; Batra S
    Pathol Oncol Res; 2012 Apr; 18(2):309-13. PubMed ID: 21901275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus.
    Singh B; Ittmann MM; Krolewski JJ
    Genes Chromosomes Cancer; 1998 Feb; 21(2):166-71. PubMed ID: 9491329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
    Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
    Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review.
    Lu YM; Cheng F; Teng LS
    Sci Rep; 2016 Sep; 6():32723. PubMed ID: 27620353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
    Lynch ED; Ostermeyer EA; Lee MK; Arena JF; Ji H; Dann J; Swisshelm K; Suchard D; MacLeod PM; Kvinnsland S; Gjertsen BT; Heimdal K; Lubs H; Møller P; King MC
    Am J Hum Genet; 1997 Dec; 61(6):1254-60. PubMed ID: 9399897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the zinc-finger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis.
    Riku M; Inaguma S; Ito H; Tsunoda T; Ikeda H; Kasai K
    Oncotarget; 2016 Feb; 7(5):5690-701. PubMed ID: 26744317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.